• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国内地 2000-2021 年围产儿出生缺陷发生率:系统评价和荟萃分析。

Perinatal prevalence of birth defects in the Mainland of China, 2000-2021: a systematic review and meta-analysis.

机构信息

Department of Epidemiology and Biostatistics, School of Public Health, Peking University, No. 38, Xueyuan Road, Haidian District, Beijing, 100191, China.

Vanke School of Public Health, Tsinghua University, No. 1, Tsinghua Garden, Haidian District, Beijing, 100084, China.

出版信息

World J Pediatr. 2024 Jul;20(7):669-681. doi: 10.1007/s12519-023-00786-8. Epub 2024 Feb 10.

DOI:10.1007/s12519-023-00786-8
PMID:38340146
Abstract

BACKGROUND

Although birth defects are of great concern globally, the latest national prevalence has not yet been quantified in China. We conducted a systematic review and meta-analysis to estimate the perinatal prevalence of birth defects in the Mainland of China between 2000 and 2021.

METHODS

We performed a systematic literature search of six databases for relevant articles published between January 1, 2000, and March 1, 2023. We included published studies that reported data on the perinatal prevalence of birth defects in the Mainland of China. The DerSimonian and Laird random-effects models were used to estimate the pooled prevalence and its 95% confidence interval (CI). We also conducted subgroup analyses and univariable meta-regressions to explore differences in prevalence by time period, geographic region, and other characteristics.

RESULTS

We included 254 studies reporting the perinatal prevalence of birth defects and 86 studies reporting only the prevalence of specific types of birth defects. Based on 254 studies covering 74,307,037 perinatal births and 985,115 cases with birth defects, the pooled perinatal prevalence of birth defects was 122.54 (95% CI 116.20-128.89) per 10,000 perinatal births in the Mainland of China during 2000-2021. Overall, the perinatal prevalence of birth defects increased from 95.60 (86.51-104.69) per 10,000 in 2000-2004 to 208.94 (175.67-242.22) per 10,000 in 2020-2021. There were also significant disparities among different geographical regions. Congenital heart defects (33.35 per 10,000), clefts of the lip and/or palate (13.52 per 10,000), polydactyly (12.82 per 10,000), neural tube defects (12.82 per 10,000), and inborn errors of metabolism (11.41 per 10,000) were the five most common types of birth defects. The perinatal prevalence among males was significantly higher than that among females (β = 2.44 × 10, P = 0.003); a higher perinatal prevalence of birth defects was observed among perinatal births whose mothers were ≥ 35 years (β = 4.34 × 10, P < 0.001).

CONCLUSION

Comprehensive and sustained efforts are needed to strengthen surveillance and detection of birth defects, improve prenatal and postnatal healthcare, and promote rehabilitation, especially in underdeveloped areas.

摘要

背景

尽管出生缺陷是全球关注的焦点,但中国最新的全国流行率尚未确定。我们进行了一项系统综述和荟萃分析,以估计 2000 年至 2021 年间中国内地围产期出生缺陷的患病率。

方法

我们对 6 个数据库进行了系统的文献检索,以检索 2000 年 1 月 1 日至 2023 年 3 月 1 日期间发表的相关文章。我们纳入了报告中国内地围产期出生缺陷患病率数据的已发表研究。使用 DerSimonian 和 Laird 随机效应模型估计汇总患病率及其 95%置信区间(CI)。我们还进行了亚组分析和单变量荟萃回归,以探讨不同时间、地理区域和其他特征的患病率差异。

结果

我们纳入了 254 项报告围产期出生缺陷患病率的研究和 86 项仅报告特定类型出生缺陷患病率的研究。基于涵盖 74307037 例围产儿和 985115 例出生缺陷病例的 254 项研究,2000-2021 年中国内地围产期出生缺陷的汇总患病率为每 10000 例围产儿 122.54(95%CI 116.20-128.89)。总体而言,出生缺陷的围产期患病率从 2000-2004 年的每 10000 例 95.60(86.51-104.69)增加到 2020-2021 年的每 10000 例 208.94(175.67-242.22)。不同地理区域之间也存在显著差异。先天性心脏病(33.35/10000)、唇腭裂(13.52/10000)、多指(12.82/10000)、神经管缺陷(12.82/10000)和先天性代谢缺陷(11.41/10000)是最常见的五种类型出生缺陷。男性的围产期出生缺陷患病率明显高于女性(β=2.44×10,P=0.003);母亲年龄≥35 岁的围产儿出生缺陷患病率较高(β=4.34×10,P<0.001)。

结论

需要综合和持续努力加强出生缺陷的监测和检测,改善产前和产后保健,并促进康复,特别是在欠发达地区。

相似文献

1
Perinatal prevalence of birth defects in the Mainland of China, 2000-2021: a systematic review and meta-analysis.中国内地 2000-2021 年围产儿出生缺陷发生率:系统评价和荟萃分析。
World J Pediatr. 2024 Jul;20(7):669-681. doi: 10.1007/s12519-023-00786-8. Epub 2024 Feb 10.
2
Prevalence of Orofacial Clefts among Live Births in China: A Systematic Review and Meta-Analysis.中国活产儿唇腭裂发生率的系统评价和 Meta 分析。
Birth Defects Res. 2017 Jul 17;109(13):1011-1019. doi: 10.1002/bdr2.1043. Epub 2017 Jun 21.
3
Multiple-micronutrient supplementation for women during pregnancy.孕期女性的多种微量营养素补充
Cochrane Database Syst Rev. 2017 Apr 13;4(4):CD004905. doi: 10.1002/14651858.CD004905.pub5.
4
Incentives for increasing prenatal care use by women in order to improve maternal and neonatal outcomes.为改善孕产妇和新生儿结局而激励女性增加产前检查的使用。
Cochrane Database Syst Rev. 2015 Dec 15;2015(12):CD009916. doi: 10.1002/14651858.CD009916.pub2.
5
Global Birth Prevalence of Spina Bifida by Folic Acid Fortification Status: A Systematic Review and Meta-Analysis.根据叶酸强化状况的全球脊柱裂出生患病率:一项系统评价和荟萃分析。
Am J Public Health. 2016 Jan;106(1):e24-34. doi: 10.2105/AJPH.2015.302902. Epub 2015 Nov 12.
6
Multiple-micronutrient supplementation for women during pregnancy.孕期妇女补充多种微量营养素
Cochrane Database Syst Rev. 2015 Nov 1;2015(11):CD004905. doi: 10.1002/14651858.CD004905.pub4.
7
Safety of topical corticosteroids in pregnancy.孕期外用糖皮质激素的安全性。
Cochrane Database Syst Rev. 2015 Oct 26;2015(10):CD007346. doi: 10.1002/14651858.CD007346.pub3.
8
Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.孕激素产前给药预防多胎妊娠妇女自发性早产。
Cochrane Database Syst Rev. 2019 Nov 20;2019(11):CD012024. doi: 10.1002/14651858.CD012024.pub3.
9
Prenatal interventions for congenital diaphragmatic hernia for improving outcomes.用于改善先天性膈疝预后的产前干预措施。
Cochrane Database Syst Rev. 2015 Nov 27;2015(11):CD008925. doi: 10.1002/14651858.CD008925.pub2.
10
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.

引用本文的文献

1
Application of chromosome microarray analysis and karyotyping in fetal cardiac abnormalities.染色体微阵列分析和核型分析在胎儿心脏异常中的应用。
Front Genet. 2025 Jun 25;16:1611388. doi: 10.3389/fgene.2025.1611388. eCollection 2025.
2
Caregiver burden and associated factors among primary caregivers of children with congenital disorders: a comparative cross-sectional study in Hunan Province, China.先天性疾病患儿主要照顾者的照顾负担及相关因素:中国湖南省的一项比较性横断面研究
BMC Nurs. 2025 May 3;24(1):491. doi: 10.1186/s12912-025-03114-9.
3
Maternal pesticide exposure and risk of birth defects: a population-based cross-sectional study in China.

本文引用的文献

1
Current status and challenges in prenatal and neonatal screening, diagnosis, and management of congenital heart disease in China.中国先天性心脏病产前及新生儿筛查、诊断和治疗的现状和挑战。
Lancet Child Adolesc Health. 2023 Jul;7(7):479-489. doi: 10.1016/S2352-4642(23)00051-2. Epub 2023 Jun 7.
2
The burden of congenital birth defects between 1990 and 2019 in China: an observational study.1990年至2019年中国先天性出生缺陷负担:一项观察性研究。
Front Pediatr. 2023 May 12;11:1170755. doi: 10.3389/fped.2023.1170755. eCollection 2023.
3
Preventing birth defects, saving lives, and promoting health equity: an urgent call to action for universal mandatory food fortification with folic acid.
母亲接触农药与出生缺陷风险:一项基于中国人群的横断面研究。
Front Public Health. 2024 Dec 6;12:1489365. doi: 10.3389/fpubh.2024.1489365. eCollection 2024.
4
Temporal trends in the prevalence of major birth defects in China: a nationwide population-based study from 2007 to 2021.中国主要出生缺陷患病率的时间趋势:一项基于 2007 年至 2021 年全国人口的研究。
World J Pediatr. 2024 Nov;20(11):1145-1154. doi: 10.1007/s12519-024-00844-9. Epub 2024 Nov 2.
5
Research needs for birth defect prevention and control in China in the genomic screening era.基因组筛查时代中国预防出生缺陷的研究需求。
BMJ. 2024 Aug 30;386:e078637. doi: 10.1136/bmj-2023-078637.
预防出生缺陷,拯救生命,促进健康公平:全面强制叶酸食物强化的紧急行动呼吁。
Lancet Glob Health. 2022 Jul;10(7):e1053-e1057. doi: 10.1016/S2214-109X(22)00213-3. Epub 2022 May 23.
4
Congenital anomalies and maternal age: A systematic review and meta-analysis of observational studies.先天性异常与母亲年龄:观察性研究的系统评价和荟萃分析。
Acta Obstet Gynecol Scand. 2022 May;101(5):484-498. doi: 10.1111/aogs.14339. Epub 2022 Mar 14.
5
Rate of Correct Use of Folic Acid Supplementation Among Pregnant Women - Beijing Municipality, China, 2017-2019.2017 - 2019年中国北京市孕妇叶酸补充剂正确使用率
China CDC Wkly. 2021 Sep 10;3(37):783-787. doi: 10.46234/ccdcw2021.194.
6
Prevention and Control of Birth Defects in China: Achievements and Challenges.中国出生缺陷的预防与控制:成就与挑战
China CDC Wkly. 2021 Sep 10;3(37):771-772. doi: 10.46234/ccdcw2021.191.
7
Selected Structural Birth Defects - Shanxi Province, China, 2000-2019.2000 - 2019年中国山西省选定的结构性出生缺陷
China CDC Wkly. 2020 Sep 11;2(37):718-722. doi: 10.46234/ccdcw2020.196.
8
A Lancet Commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China.《柳叶刀》中国女性生殖、孕产妇、新生儿、儿童及青少年健康70年委员会
Lancet. 2021 Jun 26;397(10293):2497-2536. doi: 10.1016/S0140-6736(20)32708-2. Epub 2021 May 24.
9
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
10
Protocol registration issues of systematic review and meta-analysis studies: a survey of global researchers.系统评价和荟萃分析研究的方案注册问题:全球研究人员的调查。
BMC Med Res Methodol. 2020 Aug 25;20(1):213. doi: 10.1186/s12874-020-01094-9.